Reported Feb 10, 2021 · Ongoing
Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg, 100 Tablets per bottle, Rx Only, Manufactured by:…
Nostrum Laboratories Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Nostrum Laboratories Inc · 1800 N Topping Ave · Kansas City, MO · 64120-1228
Is this the product you have?
- Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg, 100 Tablets per bottle, Rx Only
- Manufactured byNostrum Laboratories, Inc., Kansas City, MO 64120
- NDC29033-056-01
- Lot codes and dates
Lot MET20060107/2022
- Amount recalled
- 7071 bottles
Where it was sold
- Nationwide
Why it was recalled
CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Nostrum Laboratories Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.